Kaoru Ogawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kaoru Ogawa has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Akihiro Umezawa
Center for Regenerative Medicine, National Center for Child Health and Development, Tokyo, Japan
1 shared publication - Ayako Y. Murayama
Department of Physiology, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo 160-8582, Japan
1 shared publication - Hideyuki Okano
Laboratory for Marmoset Models of Brain Diseases, RIKEN Center for Brain Science
1 shared publication - Hiromasa Kawana
Department of Oral and Maxillofacial Implantology, Kanagawa Dental University, Yokosuka 238-8580, Japan
1 shared publication - Hiroyuki Ozawa
Department of Otolaryngology, Head and Neck Surgery, Keio University School of Medicine, Tokyo 160‑8582, Japan
1 shared publication - Katsuhiko Kimoto
Department of Fixed Prosthodontics, Kanagawa Dental University, Yokosuka 238-8580, Japan
1 shared publication
Latest Publications
- Open Access
Dynamic Spatiotemporal Expression Changes in Connexins of the Developing Primate’s Cochlea
Connexins are gap junction components that are essential for acquiring normal hearing ability. Up to 50% of congenital, autosomal-recessive, non-syndromic deafness can be attributed to variants in GJB2, the gene that encodes connexin 26. Gene therapies modifying the expression of connexins are a feasible treatment option for some patients with genetic hearing losses. However, the expression patterns of these proteins in the human fetus are not fully understood due to ethical concerns. Recently, the common marmoset was used as a primate animal model for the human fetus. In this study, we examined the expression patterns of connexin 26 and connexin 30 in the developing cochlea of this primate. Primate-specific spatiotemporal expression changes were revealed, which suggest the existence of primate-specific control of connexin expression patterns and specific functions of these gap junction proteins. Moreover, our results indicate that treatments for connexin-related hearing loss established in rodent models may not be appropriate for human patients, underscoring the importance of testing these treatments in primate models before applying them in human clinical trials.
Open AccessDynamic Spatiotemporal Expression Changes in Connexins of the Developing Primate’s Cochlea
Connexins are gap junction components that are essential for acquiring normal hearing ability. Up to 50% of congenital, autosomal-recessive, non-syndromic deafness can be attributed to variants in GJB2, the gene that encodes connexin 26. Gene therapies modifying the expression of connexins are a feasible treatment option for some patients with genetic hearing losses. However, the expression patterns of these proteins in the human fetus are not fully understood due to ethical concerns. Recently, the common marmoset was used as a primate animal model for the human fetus. In this study, we examined the expression patterns of connexin 26 and connexin 30 in the developing cochlea of this primate. Primate-specific spatiotemporal expression changes were revealed, which suggest the existence of primate-specific control of connexin expression patterns and specific functions of these gap junction proteins. Moreover, our results indicate that treatments for connexin-related hearing loss established in rodent models may not be appropriate for human patients, underscoring the importance of testing these treatments in primate models before applying them in human clinical trials.
- Open Access
- 11 August 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5764
Application of Mesenchymal Stem Cell Therapy and Inner Ear Regeneration for Hearing Loss: A Review
Inner and middle ear disorders are the leading cause of hearing loss, and are said to be among the greatest risk factors of dementia. The use of regenerative medicine for the treatment of inner ear disorders may offer a potential alternative to cochlear implants for hearing recovery. In this paper, we reviewed recent research and clinical applications in middle and inner ear regeneration and cell therapy. Recently, the mechanism of inner ear regeneration has gradually been elucidated. “Inner ear stem cells,” which may be considered the precursors of various cells in the inner ear, have been discovered in the cochlea and vestibule. Research indicates that cells such as hair cells, neurons, and spiral ligaments may form promising targets for inner ear regenerative therapies by the transplantation of stem cells, including mesenchymal stem cells. In addition, it is necessary to develop tests for the clinical monitoring of cell transplantation. Real-time imaging techniques and hearing rehabilitation techniques are also being investigated, and cell therapy has found clinical application in cochlear implant techniques.
- 11 August 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5764
Open AccessApplication of Mesenchymal Stem Cell Therapy and Inner Ear Regeneration for Hearing Loss: A Review
Inner and middle ear disorders are the leading cause of hearing loss, and are said to be among the greatest risk factors of dementia. The use of regenerative medicine for the treatment of inner ear disorders may offer a potential alternative to cochlear implants for hearing recovery. In this paper, we reviewed recent research and clinical applications in middle and inner ear regeneration and cell therapy. Recently, the mechanism of inner ear regeneration has gradually been elucidated. “Inner ear stem cells,” which may be considered the precursors of various cells in the inner ear, have been discovered in the cochlea and vestibule. Research indicates that cells such as hair cells, neurons, and spiral ligaments may form promising targets for inner ear regenerative therapies by the transplantation of stem cells, including mesenchymal stem cells. In addition, it is necessary to develop tests for the clinical monitoring of cell transplantation. Real-time imaging techniques and hearing rehabilitation techniques are also being investigated, and cell therapy has found clinical application in cochlear implant techniques.
- Open Access
- 17 July 2020
- Published by MDPI AG in Applied Sciences
- Vol. 10 (14) , 4922
Auricular Osseointegrated Implant Treatment: Basic Technique and Application of Computer Technology
An epithesis using osseointegrated implants as an anchorage has been proven and established as an effective means for maxillofacial rehabilitation. In this paper, we describe the basic techniques of auricular epithesis and the applications of computer technology to its execution, ranging from diagnosis to surgery, and superstructure fabrication to maintenance. The key steps of this treatment are conducting Computed Tomography (CT ) diagnosis before the operation to avoid implant penetration through the skull during the operation, embedding two implants into the section that represents the antihelix, and if possible, preserving or forming the tragus so that the edge of the epithesis is not close to the temporomandibular joint region to ensure mandibular movements are not restricted. We also discuss the applications of navigation surgery, which we are currently investigating, as well as the future prospect of augmented reality and mixed reality surgeries.
- 17 July 2020
- Published by MDPI AG in Applied Sciences
- Vol. 10 (14) , 4922
Open AccessAuricular Osseointegrated Implant Treatment: Basic Technique and Application of Computer Technology
An epithesis using osseointegrated implants as an anchorage has been proven and established as an effective means for maxillofacial rehabilitation. In this paper, we describe the basic techniques of auricular epithesis and the applications of computer technology to its execution, ranging from diagnosis to surgery, and superstructure fabrication to maintenance. The key steps of this treatment are conducting Computed Tomography (CT ) diagnosis before the operation to avoid implant penetration through the skull during the operation, embedding two implants into the section that represents the antihelix, and if possible, preserving or forming the tragus so that the edge of the epithesis is not close to the temporomandibular joint region to ensure mandibular movements are not restricted. We also discuss the applications of navigation surgery, which we are currently investigating, as well as the future prospect of augmented reality and mixed reality surgeries.